Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Sep 21 - Sep 26
A class of injectable medications known as GLP-1 agonists, sold in Canada under the brand names Ozempic and Wegovy, are approved to treat Type 2 diabetes and obesity, respectively
also labeled PNB-0408) is a synthetic oligopeptide derived from angiotensin IV, developed in the Harding and Wright labs at Washington State University and later commercialized through M3 Biotechnology and Athira Pharma
(PubMed) Lykkesfeldt J, Christen S, Wallock LM, Chang HH, Jacob RA, Ames BN
The Insurance Reality Check Both medications usually require prior authorization (insurance company paperwork), and both are covered similarly
How pricing works $19.99 First month free Copay $19.99 First month free $129 Initial visits are $129
US$ 28.02
US$ 20.28
US$ 20.89
US$ 24.11
US$ 28.44
US$ 27.83
US$ 25.65
US$ 29.11
US$ 25.41
US$ 22.05
